|
|
ISIN: |
DE0005880405 |
SCN: |
588040 |
Trading segment: |
Prime Standard |
Stock exchange: |
Frankfurt |
Financial syndicate: |
Lead-managed: Sal. Oppenheim jr. & Cie KGaA |
Stock exchange identifier: |
Gir |
First quotation: |
May 16, 2024 |
Subscription price: |
20 EUR |
Nominal value: |
1 EUR |
Shareholder structure |
Solvay Organics GmbH: | | 75% |
Free-float: | | 25% |
|
Capital stock after flotation: |
6.50 Mio. EUR |
Sales in million EUR: |
2002: | | 27.6 |
2003: | | 31.5 |
2004: | | 23,1 |
|
Earning per share: |
2002: | | -0.76 |
2003: | | -0.55 |
2004: | | -1,29 |
|
End of the business year: |
31st of December |
Number of employers: |
2002: | | 144 |
2003: | | 131 |
2004: | | 142 |
|
Board of management: |
Chief Executive Officer: | | Robert F. Link |
Chief Financial Officer: | | Klaus R. Leineweber |
Legal Affairs and HR: | | Dr. jur. Harald Mothes |
Technical Operations, R&D;: | | Dr. Hans Hiller |
| | |
|
Supervisory board: |
Chairman: | | Dr. Eberhard Piepho |
Deputy Chairman: | | Dr. Karl-Heinz Köppinger |
Member: | | Fritz Link |
|
Address: |
Girindus AG Buchenallee 20 D-51402 Bensberg, Germany |
Internet: |
www.girindus.com |
Contact: |
Peter J. Bergsteiner Telefon: +49(0)2204 – 926 900 Telefax: +49(0)2204 – 926 990 eMail: pbergsteiner@girindus.com |